Lanzamiento Enero 2027

Ensayo controlado aleatorizado2012Acceso abierto

Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery

Sultan J, Griffin SM, Di Franco F, Kirby JA, Shenton BK, Seal CJ, Davis P, Viswanath YK, Preston SR, Hayes N

The British journal of surgery · 100 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Eventos clínicos como enfermedad o muerte

Quién lo pagó

Financiación
Financiación independiente

Según la declaración de financiación del texto completo.

Publicación

Publicado
2012-01-11 · Br J Surg · vol. 99 · número 3 · págs. 346–355
Editorial
Oxford University Press
Citado
134 citas · más que el 99% de estudios similares · 10.0× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
30 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Clinical Nutrition and Gastroenterology · Fatty Acid Research and Health · Enhanced Recovery After Surgery
Palabras clave
omega-3 fatty acids, immunonutrition, enteral nutrition, esophagectomy, gastrectomy, perioperative nutrition, HLA-DR expression, monocytes, T cells, n-6/n-3 ratio, postoperative morbidity, immunosuppression
MeSH
t-lymphocytes, monocytes, humans, esophageal neoplasms, stomach neoplasms, postoperative complications, fatty acids, omega-3, fatty acids, fatty acids, omega-6, c-reactive protein, hla-dr antigens, enteral nutrition, postoperative care, preoperative care, esophagectomy, gastrectomy, analysis of variance, prospective studies, dietary supplements, adult, aged, middle aged, female, male

10 autores

  • Javed Sultan🇬🇧Royal Victoria Infirmary
  • S M Griffin🇬🇧Royal Victoria Infirmary
  • F Di Franco🇬🇧Royal Victoria Infirmary
  • John Andrew Kirby🇬🇧Newcastle University
  • Brian Keith Shenton🇬🇧Newcastle University
  • Chris J. Seal🇬🇧Newcastle University
  • Philip J. Davis🇬🇧James Cook University Hospital
  • Y K S Viswanath🇬🇧James Cook University Hospital
  • Shaun R. Preston🇬🇧Royal Victoria Infirmary
  • Nick Hayes🇬🇧Royal Victoria Infirmary

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Oesophagogastric cancer surgery is immunosuppressive. This may be modulated by omega-3 fatty acids (O-3FAs). The aim of this study was to assess the effect of perioperative O-3FAs on clinical outcome and immune function after oesophagogastric cancer surgery.

Methods

Patients undergoing subtotal oesophagectomy and total gastrectomy were recruited and allocated randomly to an O-3FA enteral immunoenhancing diet (IED) or standard enteral nutrition (SEN) for 7 days before and after surgery, or to postoperative supplementation alone (control group). Clinical outcome, fatty acid concentrations, and HLA-DR expression on monocytes and activated T lymphocytes were determined before and after operation.

Results

Of 221 patients recruited, 26 were excluded. Groups (IED, 66; SEN, 63; control, 66) were matched for age, malnutrition and co-morbidity. There were no differences in morbidity (P = 0·646), mortality (P = 1·000) or hospital stay (P = 0·701) between the groups. O-3FA concentrations were higher in the IED group after supplementation (P < 0·001). The ratio of omega-6 fatty acid to O-3FA was 1·9:1, 4·1:1 and 4·8:1 on the day before surgery in the IED, SEN and control groups (P < 0·001). There were no differences between the groups in HLA-DR expression in either monocytes (P = 0·538) or activated T lymphocytes (P = 0·204).

Conclusion

Despite a significant increase in plasma concentrations of O-3FA, immunonutrition with O-3FA did not affect overall HLA-DR expression on leucocytes or clinical outcome following oesophagogastric cancer surgery.

Registration number

ISRCTN43730758 (http://www.controlled-trials.com).

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.